MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Atypical Psychosis in Parkinson Disease: A Retrospective Study on 24-Hour Continuous Subcutaneous Infusion Foslevodopa/Foscarbidopa Therapy

    K. Ikenaka, K. Kakuda, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify clinical predictors of continuous subcutaneous infusion (CSCI)-induced psychosis to understand its potential mechanisms and evaluate predictive measures for its…
  • 2025 International Congress

    Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)

    A. Lemkow, A. Kuan, J. Lam, F. Vila-Rodriguez, M. Mckeown, J. Squires, A. Howard, S. Appel-Cresswell (Vancouver, Canada)

    Objective: Objective: To assess the impact of probiotic supplementation on depression symptoms and the gut microbiome in people living with Parkinson’s disease (PwPD). Background: Background:…
  • 2025 International Congress

    Characteristics of Visual Hallucinations in Lewy Body Dementia

    Y. Luo, RY. Lo, J. Wang (Hsinchu, Taiwan)

    Objective: To investigate the risk and the content of visual hallucination (VH) among patients with Lewy body dementia (LBD) within the cultural background of Taiwan.…
  • 2025 International Congress

    Long-Term Dementia Risk in the General Parkinson Disease Population

    J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

    Objective: To estimate the long-term risk of developing dementia in the general Parkinson’s disease (PD) population and to assess the influence of age at PD…
  • 2025 International Congress

    Parkinson disease subtype stability and eventual convergence

    H. Lessov-Schlaggar, A. Eid, T. Cash, E. Foster, B. Maiti, H. Hwang, R. Perrin, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To determine the longitudinal stability of Parkinson disease (PD) subtype membership. Background: Previous research demonstrates distinct PD subtypes of “motor only”, “psychiatric & motor”,…
  • 2025 International Congress

    Subthalamic Deep Brain Stimulation Modulates Cognitive-Motor Integration in Parkinson’s Disease: Insights from a Dual-task fNIRS Study

    YQ. Zhang, JP. Li, Y. Liang (Beijing, China)

    Objective: To investigate the effects of STN-DBS on cognitive-motor dual-task performance in PD patients using an executive function-motor function dual-task paradigm combined with functional near-infrared…
  • 2025 International Congress

    Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

    E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

    Objective: To investigate the neuropsychological profiles of White, Japanese, and other Asian American or Pacific Islander (OAAPI) patients with Parkinson’s disease (PD) identified as candidates…
  • 2025 International Congress

    Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

    J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)

    Objective: To assess a multidisciplinary hospital day service for Parkinson’s disease and fall-related concerns, identify service gaps, and evaluate its 5-year impact. Background: The Day…
  • 2025 International Congress

    Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

    C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)

    Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…
  • 2025 International Congress

    Efficacy of adhering to a Ketogenic Diet in Parkinson’s Disease: a Systematic Review and Meta-Analysis

    G. Guindani Maia, V. Ritt Xavier, V. Serafim, M. Neto, L. Nardi Motta, V. Müller, I. Alicia Fink, AC. Sgarioni Viapiana, MF. Peruci Felippe, L. Bedatti Koehler, C. Rieder (Porto Alegre, Brazil)

    Objective: We aimed to analyse the efficacy of Ketogenic Diet (KD) in metabolic and motor characteristics of patients with Parkinson's Disease (PD). Background: Many studies…
  • « Previous Page
  • 1
  • …
  • 381
  • 382
  • 383
  • 384
  • 385
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley